nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Conjugated Estrogens—osteoporosis	0.106	0.167	CbGbCtD
Ezetimibe—UGT1A1—Estradiol—osteoporosis	0.0692	0.11	CbGbCtD
Ezetimibe—ABCC2—Ethinyl Estradiol—osteoporosis	0.0654	0.103	CbGbCtD
Ezetimibe—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0546	0.0864	CbGbCtD
Ezetimibe—ABCC2—Conjugated Estrogens—osteoporosis	0.048	0.0759	CbGbCtD
Ezetimibe—SLCO1B1—Estradiol—osteoporosis	0.0479	0.0759	CbGbCtD
Ezetimibe—ABCG2—Conjugated Estrogens—osteoporosis	0.0434	0.0687	CbGbCtD
Ezetimibe—ABCG2—Estradiol—osteoporosis	0.0381	0.0603	CbGbCtD
Ezetimibe—ABCB1—Ethinyl Estradiol—osteoporosis	0.0213	0.0337	CbGbCtD
Ezetimibe—CYP3A4—Calcitriol—osteoporosis	0.0198	0.0314	CbGbCtD
Ezetimibe—CYP3A4—Estropipate—osteoporosis	0.0198	0.0314	CbGbCtD
Ezetimibe—CYP3A4—Ergocalciferol—osteoporosis	0.0158	0.0251	CbGbCtD
Ezetimibe—ABCB1—Conjugated Estrogens—osteoporosis	0.0156	0.0248	CbGbCtD
Ezetimibe—ABCB1—Estradiol—osteoporosis	0.0137	0.0217	CbGbCtD
Ezetimibe—CYP3A4—Raloxifene—osteoporosis	0.0132	0.0209	CbGbCtD
Ezetimibe—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0128	0.0202	CbGbCtD
Ezetimibe—CYP3A4—Cholecalciferol—osteoporosis	0.0102	0.0162	CbGbCtD
Ezetimibe—CYP3A4—Conjugated Estrogens—osteoporosis	0.00937	0.0148	CbGbCtD
Ezetimibe—CYP3A4—Estradiol—osteoporosis	0.00823	0.013	CbGbCtD
Ezetimibe—Body temperature increased—Calcitriol—osteoporosis	0.00025	0.00102	CcSEcCtD
Ezetimibe—Angioedema—Conjugated Estrogens—osteoporosis	0.000249	0.00101	CcSEcCtD
Ezetimibe—Pharyngitis—Estradiol—osteoporosis	0.000248	0.00101	CcSEcCtD
Ezetimibe—Hypersensitivity—Estropipate—osteoporosis	0.000248	0.00101	CcSEcCtD
Ezetimibe—Nervous system disorder—Pamidronate—osteoporosis	0.000248	0.00101	CcSEcCtD
Ezetimibe—Thrombocytopenia—Pamidronate—osteoporosis	0.000247	0.00101	CcSEcCtD
Ezetimibe—Vomiting—Etidronic acid—osteoporosis	0.000247	0.00101	CcSEcCtD
Ezetimibe—Cough—Zoledronate—osteoporosis	0.000247	0.00101	CcSEcCtD
Ezetimibe—Oedema peripheral—Estradiol—osteoporosis	0.000247	0.00101	CcSEcCtD
Ezetimibe—Connective tissue disorder—Estradiol—osteoporosis	0.000246	0.001	CcSEcCtD
Ezetimibe—Rash—Etidronic acid—osteoporosis	0.000245	0.001	CcSEcCtD
Ezetimibe—Dermatitis—Etidronic acid—osteoporosis	0.000245	0.000999	CcSEcCtD
Ezetimibe—Hypertension—Zoledronate—osteoporosis	0.000244	0.000996	CcSEcCtD
Ezetimibe—Hypersensitivity—Alendronate—osteoporosis	0.000244	0.000995	CcSEcCtD
Ezetimibe—Headache—Etidronic acid—osteoporosis	0.000244	0.000993	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000242	0.000988	CcSEcCtD
Ezetimibe—Asthenia—Estropipate—osteoporosis	0.000241	0.000984	CcSEcCtD
Ezetimibe—Arthralgia—Zoledronate—osteoporosis	0.000241	0.000982	CcSEcCtD
Ezetimibe—Myalgia—Zoledronate—osteoporosis	0.000241	0.000982	CcSEcCtD
Ezetimibe—Chest pain—Zoledronate—osteoporosis	0.000241	0.000982	CcSEcCtD
Ezetimibe—Palpitations—Conjugated Estrogens—osteoporosis	0.000241	0.000981	CcSEcCtD
Ezetimibe—Insomnia—Risedronate—osteoporosis	0.00024	0.00098	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000239	0.000975	CcSEcCtD
Ezetimibe—Paraesthesia—Risedronate—osteoporosis	0.000239	0.000973	CcSEcCtD
Ezetimibe—Pruritus—Estropipate—osteoporosis	0.000238	0.00097	CcSEcCtD
Ezetimibe—Discomfort—Zoledronate—osteoporosis	0.000238	0.00097	CcSEcCtD
Ezetimibe—Asthenia—Alendronate—osteoporosis	0.000238	0.000969	CcSEcCtD
Ezetimibe—Hypersensitivity—Ibandronate—osteoporosis	0.000238	0.000969	CcSEcCtD
Ezetimibe—Cough—Conjugated Estrogens—osteoporosis	0.000238	0.000969	CcSEcCtD
Ezetimibe—Dyspnoea—Risedronate—osteoporosis	0.000237	0.000966	CcSEcCtD
Ezetimibe—Erythema multiforme—Estradiol—osteoporosis	0.000237	0.000965	CcSEcCtD
Ezetimibe—Dry mouth—Zoledronate—osteoporosis	0.000235	0.00096	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000235	0.00096	CcSEcCtD
Ezetimibe—Fatigue—Ethinyl Estradiol—osteoporosis	0.000235	0.000958	CcSEcCtD
Ezetimibe—Pruritus—Alendronate—osteoporosis	0.000234	0.000956	CcSEcCtD
Ezetimibe—Dyspepsia—Risedronate—osteoporosis	0.000234	0.000954	CcSEcCtD
Ezetimibe—Constipation—Ethinyl Estradiol—osteoporosis	0.000233	0.000951	CcSEcCtD
Ezetimibe—Confusional state—Zoledronate—osteoporosis	0.000233	0.000949	CcSEcCtD
Ezetimibe—Hypersensitivity—Calcitriol—osteoporosis	0.000233	0.000949	CcSEcCtD
Ezetimibe—Flushing—Estradiol—osteoporosis	0.000232	0.000947	CcSEcCtD
Ezetimibe—Chest pain—Conjugated Estrogens—osteoporosis	0.000232	0.000945	CcSEcCtD
Ezetimibe—Myalgia—Conjugated Estrogens—osteoporosis	0.000232	0.000945	CcSEcCtD
Ezetimibe—Arthralgia—Conjugated Estrogens—osteoporosis	0.000232	0.000945	CcSEcCtD
Ezetimibe—Asthenia—Ibandronate—osteoporosis	0.000231	0.000944	CcSEcCtD
Ezetimibe—Nausea—Etidronic acid—osteoporosis	0.000231	0.000942	CcSEcCtD
Ezetimibe—Anaphylactic shock—Zoledronate—osteoporosis	0.000231	0.000941	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00023	0.000939	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00023	0.000939	CcSEcCtD
Ezetimibe—Diarrhoea—Estropipate—osteoporosis	0.00023	0.000938	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Risedronate—osteoporosis	0.000229	0.000936	CcSEcCtD
Ezetimibe—Infection—Zoledronate—osteoporosis	0.000229	0.000935	CcSEcCtD
Ezetimibe—Fatigue—Risedronate—osteoporosis	0.000229	0.000935	CcSEcCtD
Ezetimibe—Insomnia—Pamidronate—osteoporosis	0.000229	0.000932	CcSEcCtD
Ezetimibe—Pruritus—Ibandronate—osteoporosis	0.000228	0.000931	CcSEcCtD
Ezetimibe—Pain—Risedronate—osteoporosis	0.000227	0.000927	CcSEcCtD
Ezetimibe—Constipation—Risedronate—osteoporosis	0.000227	0.000927	CcSEcCtD
Ezetimibe—Angiopathy—Estradiol—osteoporosis	0.000227	0.000926	CcSEcCtD
Ezetimibe—Paraesthesia—Pamidronate—osteoporosis	0.000227	0.000925	CcSEcCtD
Ezetimibe—Diarrhoea—Alendronate—osteoporosis	0.000227	0.000924	CcSEcCtD
Ezetimibe—Asthenia—Calcitriol—osteoporosis	0.000227	0.000924	CcSEcCtD
Ezetimibe—Nervous system disorder—Zoledronate—osteoporosis	0.000226	0.000923	CcSEcCtD
Ezetimibe—Immune system disorder—Estradiol—osteoporosis	0.000226	0.000922	CcSEcCtD
Ezetimibe—Thrombocytopenia—Zoledronate—osteoporosis	0.000226	0.000922	CcSEcCtD
Ezetimibe—Mediastinal disorder—Estradiol—osteoporosis	0.000226	0.00092	CcSEcCtD
Ezetimibe—Dyspnoea—Pamidronate—osteoporosis	0.000225	0.000919	CcSEcCtD
Ezetimibe—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000225	0.000916	CcSEcCtD
Ezetimibe—Skin disorder—Zoledronate—osteoporosis	0.000224	0.000914	CcSEcCtD
Ezetimibe—Pruritus—Calcitriol—osteoporosis	0.000223	0.000911	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000223	0.000909	CcSEcCtD
Ezetimibe—Diarrhoea—Raloxifene—osteoporosis	0.000223	0.000909	CcSEcCtD
Ezetimibe—Dyspepsia—Pamidronate—osteoporosis	0.000222	0.000907	CcSEcCtD
Ezetimibe—Dizziness—Estropipate—osteoporosis	0.000222	0.000907	CcSEcCtD
Ezetimibe—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000222	0.000906	CcSEcCtD
Ezetimibe—Alopecia—Estradiol—osteoporosis	0.000221	0.000902	CcSEcCtD
Ezetimibe—Infection—Conjugated Estrogens—osteoporosis	0.000221	0.0009	CcSEcCtD
Ezetimibe—Diarrhoea—Ibandronate—osteoporosis	0.000221	0.0009	CcSEcCtD
Ezetimibe—Decreased appetite—Pamidronate—osteoporosis	0.00022	0.000896	CcSEcCtD
Ezetimibe—Mental disorder—Estradiol—osteoporosis	0.000219	0.000894	CcSEcCtD
Ezetimibe—Dizziness—Alendronate—osteoporosis	0.000219	0.000893	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000218	0.00089	CcSEcCtD
Ezetimibe—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000218	0.000889	CcSEcCtD
Ezetimibe—Erythema—Estradiol—osteoporosis	0.000218	0.000889	CcSEcCtD
Ezetimibe—Malnutrition—Estradiol—osteoporosis	0.000218	0.000889	CcSEcCtD
Ezetimibe—Fatigue—Pamidronate—osteoporosis	0.000218	0.000888	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Risedronate—osteoporosis	0.000217	0.000886	CcSEcCtD
Ezetimibe—Urticaria—Ethinyl Estradiol—osteoporosis	0.000217	0.000883	CcSEcCtD
Ezetimibe—Pain—Pamidronate—osteoporosis	0.000216	0.000881	CcSEcCtD
Ezetimibe—Constipation—Pamidronate—osteoporosis	0.000216	0.000881	CcSEcCtD
Ezetimibe—Diarrhoea—Calcitriol—osteoporosis	0.000216	0.000881	CcSEcCtD
Ezetimibe—Skin disorder—Conjugated Estrogens—osteoporosis	0.000216	0.00088	CcSEcCtD
Ezetimibe—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000215	0.000879	CcSEcCtD
Ezetimibe—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000215	0.000879	CcSEcCtD
Ezetimibe—Dizziness—Raloxifene—osteoporosis	0.000215	0.000879	CcSEcCtD
Ezetimibe—Flatulence—Estradiol—osteoporosis	0.000215	0.000876	CcSEcCtD
Ezetimibe—Vomiting—Estropipate—osteoporosis	0.000214	0.000872	CcSEcCtD
Ezetimibe—Dizziness—Ibandronate—osteoporosis	0.000213	0.00087	CcSEcCtD
Ezetimibe—Rash—Estropipate—osteoporosis	0.000212	0.000865	CcSEcCtD
Ezetimibe—Dermatitis—Estropipate—osteoporosis	0.000212	0.000864	CcSEcCtD
Ezetimibe—Urticaria—Risedronate—osteoporosis	0.000211	0.000861	CcSEcCtD
Ezetimibe—Back pain—Estradiol—osteoporosis	0.000211	0.00086	CcSEcCtD
Ezetimibe—Headache—Estropipate—osteoporosis	0.000211	0.000859	CcSEcCtD
Ezetimibe—Vomiting—Alendronate—osteoporosis	0.000211	0.000859	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00021	0.000857	CcSEcCtD
Ezetimibe—Abdominal pain—Risedronate—osteoporosis	0.00021	0.000857	CcSEcCtD
Ezetimibe—Body temperature increased—Risedronate—osteoporosis	0.00021	0.000857	CcSEcCtD
Ezetimibe—Muscle spasms—Estradiol—osteoporosis	0.00021	0.000854	CcSEcCtD
Ezetimibe—Rash—Alendronate—osteoporosis	0.000209	0.000852	CcSEcCtD
Ezetimibe—Insomnia—Zoledronate—osteoporosis	0.000209	0.000851	CcSEcCtD
Ezetimibe—Dermatitis—Alendronate—osteoporosis	0.000209	0.000851	CcSEcCtD
Ezetimibe—Feeling abnormal—Pamidronate—osteoporosis	0.000208	0.000849	CcSEcCtD
Ezetimibe—Headache—Alendronate—osteoporosis	0.000208	0.000846	CcSEcCtD
Ezetimibe—Paraesthesia—Zoledronate—osteoporosis	0.000207	0.000845	CcSEcCtD
Ezetimibe—Vomiting—Raloxifene—osteoporosis	0.000207	0.000845	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Pamidronate—osteoporosis	0.000207	0.000843	CcSEcCtD
Ezetimibe—Dyspnoea—Zoledronate—osteoporosis	0.000206	0.000839	CcSEcCtD
Ezetimibe—Rash—Raloxifene—osteoporosis	0.000205	0.000838	CcSEcCtD
Ezetimibe—Dermatitis—Raloxifene—osteoporosis	0.000205	0.000837	CcSEcCtD
Ezetimibe—Vomiting—Ibandronate—osteoporosis	0.000205	0.000836	CcSEcCtD
Ezetimibe—Headache—Raloxifene—osteoporosis	0.000204	0.000832	CcSEcCtD
Ezetimibe—Rash—Ibandronate—osteoporosis	0.000203	0.000829	CcSEcCtD
Ezetimibe—Dermatitis—Ibandronate—osteoporosis	0.000203	0.000829	CcSEcCtD
Ezetimibe—Dyspepsia—Zoledronate—osteoporosis	0.000203	0.000828	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000202	0.000826	CcSEcCtD
Ezetimibe—Ill-defined disorder—Estradiol—osteoporosis	0.000202	0.000825	CcSEcCtD
Ezetimibe—Headache—Ibandronate—osteoporosis	0.000202	0.000824	CcSEcCtD
Ezetimibe—Insomnia—Conjugated Estrogens—osteoporosis	0.000201	0.00082	CcSEcCtD
Ezetimibe—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000201	0.000819	CcSEcCtD
Ezetimibe—Vomiting—Calcitriol—osteoporosis	0.000201	0.000819	CcSEcCtD
Ezetimibe—Decreased appetite—Zoledronate—osteoporosis	0.000201	0.000818	CcSEcCtD
Ezetimibe—Nausea—Estropipate—osteoporosis	0.0002	0.000815	CcSEcCtD
Ezetimibe—Abdominal pain—Pamidronate—osteoporosis	0.0002	0.000815	CcSEcCtD
Ezetimibe—Body temperature increased—Pamidronate—osteoporosis	0.0002	0.000815	CcSEcCtD
Ezetimibe—Paraesthesia—Conjugated Estrogens—osteoporosis	0.0002	0.000814	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000199	0.000813	CcSEcCtD
Ezetimibe—Angioedema—Estradiol—osteoporosis	0.000199	0.000812	CcSEcCtD
Ezetimibe—Rash—Calcitriol—osteoporosis	0.000199	0.000812	CcSEcCtD
Ezetimibe—Fatigue—Zoledronate—osteoporosis	0.000199	0.000811	CcSEcCtD
Ezetimibe—Dermatitis—Calcitriol—osteoporosis	0.000199	0.000811	CcSEcCtD
Ezetimibe—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000198	0.000808	CcSEcCtD
Ezetimibe—Headache—Calcitriol—osteoporosis	0.000198	0.000807	CcSEcCtD
Ezetimibe—Constipation—Zoledronate—osteoporosis	0.000197	0.000805	CcSEcCtD
Ezetimibe—Pain—Zoledronate—osteoporosis	0.000197	0.000805	CcSEcCtD
Ezetimibe—Nausea—Alendronate—osteoporosis	0.000197	0.000802	CcSEcCtD
Ezetimibe—Malaise—Estradiol—osteoporosis	0.000197	0.000801	CcSEcCtD
Ezetimibe—Hypersensitivity—Risedronate—osteoporosis	0.000196	0.000799	CcSEcCtD
Ezetimibe—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000196	0.000798	CcSEcCtD
Ezetimibe—Asthenia—Ethinyl Estradiol—osteoporosis	0.000196	0.000798	CcSEcCtD
Ezetimibe—Nausea—Raloxifene—osteoporosis	0.000194	0.000789	CcSEcCtD
Ezetimibe—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000193	0.000788	CcSEcCtD
Ezetimibe—Pruritus—Ethinyl Estradiol—osteoporosis	0.000193	0.000787	CcSEcCtD
Ezetimibe—Palpitations—Estradiol—osteoporosis	0.000193	0.000785	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000192	0.000782	CcSEcCtD
Ezetimibe—Fatigue—Conjugated Estrogens—osteoporosis	0.000192	0.000781	CcSEcCtD
Ezetimibe—Nausea—Ibandronate—osteoporosis	0.000192	0.000781	CcSEcCtD
Ezetimibe—Asthenia—Risedronate—osteoporosis	0.000191	0.000778	CcSEcCtD
Ezetimibe—Feeling abnormal—Zoledronate—osteoporosis	0.00019	0.000776	CcSEcCtD
Ezetimibe—Cough—Estradiol—osteoporosis	0.00019	0.000776	CcSEcCtD
Ezetimibe—Pain—Conjugated Estrogens—osteoporosis	0.00019	0.000775	CcSEcCtD
Ezetimibe—Constipation—Conjugated Estrogens—osteoporosis	0.00019	0.000775	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Zoledronate—osteoporosis	0.000189	0.00077	CcSEcCtD
Ezetimibe—Hypertension—Estradiol—osteoporosis	0.000188	0.000767	CcSEcCtD
Ezetimibe—Pruritus—Risedronate—osteoporosis	0.000188	0.000767	CcSEcCtD
Ezetimibe—Nausea—Calcitriol—osteoporosis	0.000188	0.000765	CcSEcCtD
Ezetimibe—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000187	0.000761	CcSEcCtD
Ezetimibe—Hypersensitivity—Pamidronate—osteoporosis	0.000186	0.000759	CcSEcCtD
Ezetimibe—Chest pain—Estradiol—osteoporosis	0.000186	0.000757	CcSEcCtD
Ezetimibe—Myalgia—Estradiol—osteoporosis	0.000186	0.000757	CcSEcCtD
Ezetimibe—Arthralgia—Estradiol—osteoporosis	0.000186	0.000757	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000184	0.000751	CcSEcCtD
Ezetimibe—Urticaria—Zoledronate—osteoporosis	0.000183	0.000748	CcSEcCtD
Ezetimibe—Discomfort—Estradiol—osteoporosis	0.000183	0.000748	CcSEcCtD
Ezetimibe—Abdominal pain—Zoledronate—osteoporosis	0.000182	0.000744	CcSEcCtD
Ezetimibe—Body temperature increased—Zoledronate—osteoporosis	0.000182	0.000744	CcSEcCtD
Ezetimibe—Diarrhoea—Risedronate—osteoporosis	0.000182	0.000742	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000182	0.000741	CcSEcCtD
Ezetimibe—Dry mouth—Estradiol—osteoporosis	0.000181	0.00074	CcSEcCtD
Ezetimibe—Asthenia—Pamidronate—osteoporosis	0.000181	0.000739	CcSEcCtD
Ezetimibe—Dizziness—Ethinyl Estradiol—osteoporosis	0.00018	0.000735	CcSEcCtD
Ezetimibe—Confusional state—Estradiol—osteoporosis	0.000179	0.000731	CcSEcCtD
Ezetimibe—Pruritus—Pamidronate—osteoporosis	0.000179	0.000729	CcSEcCtD
Ezetimibe—Anaphylactic shock—Estradiol—osteoporosis	0.000178	0.000725	CcSEcCtD
Ezetimibe—Infection—Estradiol—osteoporosis	0.000177	0.000721	CcSEcCtD
Ezetimibe—Urticaria—Conjugated Estrogens—osteoporosis	0.000177	0.00072	CcSEcCtD
Ezetimibe—Dizziness—Risedronate—osteoporosis	0.000176	0.000717	CcSEcCtD
Ezetimibe—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000176	0.000716	CcSEcCtD
Ezetimibe—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000176	0.000716	CcSEcCtD
Ezetimibe—Nervous system disorder—Estradiol—osteoporosis	0.000174	0.000711	CcSEcCtD
Ezetimibe—Vomiting—Ethinyl Estradiol—osteoporosis	0.000173	0.000707	CcSEcCtD
Ezetimibe—Diarrhoea—Pamidronate—osteoporosis	0.000173	0.000705	CcSEcCtD
Ezetimibe—Skin disorder—Estradiol—osteoporosis	0.000173	0.000705	CcSEcCtD
Ezetimibe—Rash—Ethinyl Estradiol—osteoporosis	0.000172	0.000701	CcSEcCtD
Ezetimibe—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000172	0.0007	CcSEcCtD
Ezetimibe—Headache—Ethinyl Estradiol—osteoporosis	0.000171	0.000696	CcSEcCtD
Ezetimibe—Hypersensitivity—Zoledronate—osteoporosis	0.00017	0.000693	CcSEcCtD
Ezetimibe—Vomiting—Risedronate—osteoporosis	0.000169	0.000689	CcSEcCtD
Ezetimibe—Rash—Risedronate—osteoporosis	0.000168	0.000683	CcSEcCtD
Ezetimibe—Dermatitis—Risedronate—osteoporosis	0.000167	0.000683	CcSEcCtD
Ezetimibe—Dizziness—Pamidronate—osteoporosis	0.000167	0.000681	CcSEcCtD
Ezetimibe—Headache—Risedronate—osteoporosis	0.000167	0.000679	CcSEcCtD
Ezetimibe—Asthenia—Zoledronate—osteoporosis	0.000166	0.000675	CcSEcCtD
Ezetimibe—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000164	0.000668	CcSEcCtD
Ezetimibe—Pruritus—Zoledronate—osteoporosis	0.000163	0.000666	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000162	0.000661	CcSEcCtD
Ezetimibe—Nausea—Ethinyl Estradiol—osteoporosis	0.000162	0.00066	CcSEcCtD
Ezetimibe—Insomnia—Estradiol—osteoporosis	0.000161	0.000656	CcSEcCtD
Ezetimibe—Vomiting—Pamidronate—osteoporosis	0.000161	0.000655	CcSEcCtD
Ezetimibe—Paraesthesia—Estradiol—osteoporosis	0.00016	0.000651	CcSEcCtD
Ezetimibe—Asthenia—Conjugated Estrogens—osteoporosis	0.000159	0.00065	CcSEcCtD
Ezetimibe—Rash—Pamidronate—osteoporosis	0.000159	0.00065	CcSEcCtD
Ezetimibe—Dermatitis—Pamidronate—osteoporosis	0.000159	0.000649	CcSEcCtD
Ezetimibe—Dyspnoea—Estradiol—osteoporosis	0.000159	0.000647	CcSEcCtD
Ezetimibe—Headache—Pamidronate—osteoporosis	0.000158	0.000646	CcSEcCtD
Ezetimibe—Diarrhoea—Zoledronate—osteoporosis	0.000158	0.000644	CcSEcCtD
Ezetimibe—Nausea—Risedronate—osteoporosis	0.000158	0.000644	CcSEcCtD
Ezetimibe—Pruritus—Conjugated Estrogens—osteoporosis	0.000157	0.000641	CcSEcCtD
Ezetimibe—Dyspepsia—Estradiol—osteoporosis	0.000157	0.000638	CcSEcCtD
Ezetimibe—Decreased appetite—Estradiol—osteoporosis	0.000155	0.000631	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Estradiol—osteoporosis	0.000154	0.000626	CcSEcCtD
Ezetimibe—Fatigue—Estradiol—osteoporosis	0.000153	0.000625	CcSEcCtD
Ezetimibe—Dizziness—Zoledronate—osteoporosis	0.000153	0.000622	CcSEcCtD
Ezetimibe—Constipation—Estradiol—osteoporosis	0.000152	0.00062	CcSEcCtD
Ezetimibe—Pain—Estradiol—osteoporosis	0.000152	0.00062	CcSEcCtD
Ezetimibe—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000152	0.00062	CcSEcCtD
Ezetimibe—Nausea—Pamidronate—osteoporosis	0.00015	0.000612	CcSEcCtD
Ezetimibe—Dizziness—Conjugated Estrogens—osteoporosis	0.000147	0.000599	CcSEcCtD
Ezetimibe—Vomiting—Zoledronate—osteoporosis	0.000147	0.000598	CcSEcCtD
Ezetimibe—Feeling abnormal—Estradiol—osteoporosis	0.000147	0.000598	CcSEcCtD
Ezetimibe—Rash—Zoledronate—osteoporosis	0.000146	0.000593	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Estradiol—osteoporosis	0.000145	0.000593	CcSEcCtD
Ezetimibe—Dermatitis—Zoledronate—osteoporosis	0.000145	0.000593	CcSEcCtD
Ezetimibe—Headache—Zoledronate—osteoporosis	0.000145	0.00059	CcSEcCtD
Ezetimibe—Vomiting—Conjugated Estrogens—osteoporosis	0.000141	0.000576	CcSEcCtD
Ezetimibe—Urticaria—Estradiol—osteoporosis	0.000141	0.000576	CcSEcCtD
Ezetimibe—Abdominal pain—Estradiol—osteoporosis	0.000141	0.000573	CcSEcCtD
Ezetimibe—Body temperature increased—Estradiol—osteoporosis	0.000141	0.000573	CcSEcCtD
Ezetimibe—Rash—Conjugated Estrogens—osteoporosis	0.00014	0.000571	CcSEcCtD
Ezetimibe—Dermatitis—Conjugated Estrogens—osteoporosis	0.00014	0.000571	CcSEcCtD
Ezetimibe—Headache—Conjugated Estrogens—osteoporosis	0.000139	0.000568	CcSEcCtD
Ezetimibe—Nausea—Zoledronate—osteoporosis	0.000137	0.000559	CcSEcCtD
Ezetimibe—Nausea—Conjugated Estrogens—osteoporosis	0.000132	0.000538	CcSEcCtD
Ezetimibe—Hypersensitivity—Estradiol—osteoporosis	0.000131	0.000534	CcSEcCtD
Ezetimibe—Asthenia—Estradiol—osteoporosis	0.000128	0.00052	CcSEcCtD
Ezetimibe—Pruritus—Estradiol—osteoporosis	0.000126	0.000513	CcSEcCtD
Ezetimibe—Diarrhoea—Estradiol—osteoporosis	0.000122	0.000496	CcSEcCtD
Ezetimibe—Dizziness—Estradiol—osteoporosis	0.000118	0.00048	CcSEcCtD
Ezetimibe—Vomiting—Estradiol—osteoporosis	0.000113	0.000461	CcSEcCtD
Ezetimibe—Rash—Estradiol—osteoporosis	0.000112	0.000457	CcSEcCtD
Ezetimibe—Dermatitis—Estradiol—osteoporosis	0.000112	0.000457	CcSEcCtD
Ezetimibe—Headache—Estradiol—osteoporosis	0.000111	0.000454	CcSEcCtD
Ezetimibe—Nausea—Estradiol—osteoporosis	0.000106	0.000431	CcSEcCtD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.93e-05	0.000725	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—RAP1A—osteoporosis	8.76e-05	0.000712	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ATIC—osteoporosis	8.71e-05	0.000708	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PNP—osteoporosis	8.71e-05	0.000708	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—FDPS—osteoporosis	8.55e-05	0.000694	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PKM—osteoporosis	8.55e-05	0.000694	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PKM—osteoporosis	8.55e-05	0.000694	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—FDPS—osteoporosis	8.55e-05	0.000694	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	8.46e-05	0.000687	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.27e-05	0.000671	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ADCY5—osteoporosis	8.21e-05	0.000667	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.21e-05	0.000667	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GPX1—osteoporosis	8.18e-05	0.000665	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PGLS—osteoporosis	8.1e-05	0.000658	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GPD2—osteoporosis	8.1e-05	0.000658	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PGLS—osteoporosis	8.1e-05	0.000658	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GPD2—osteoporosis	8.1e-05	0.000658	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.04e-05	0.000653	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	8e-05	0.00065	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—POMC—osteoporosis	7.97e-05	0.000647	CbGpPWpGaD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.94e-05	0.000645	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ADCY5—osteoporosis	7.9e-05	0.000642	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GPX1—osteoporosis	7.88e-05	0.00064	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—MTHFR—osteoporosis	7.55e-05	0.000614	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PNP—osteoporosis	7.41e-05	0.000602	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ATIC—osteoporosis	7.41e-05	0.000602	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—OXCT1—osteoporosis	7.41e-05	0.000602	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CA2—osteoporosis	7.41e-05	0.000602	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PNP—osteoporosis	7.41e-05	0.000602	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ATIC—osteoporosis	7.41e-05	0.000602	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—POMC—osteoporosis	7.36e-05	0.000598	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—MTHFR—osteoporosis	7.27e-05	0.000591	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MGLL—osteoporosis	7.22e-05	0.000587	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ENO1—osteoporosis	7.08e-05	0.000575	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—TGFB1—osteoporosis	7.01e-05	0.000569	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.98e-05	0.000567	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PSMA5—osteoporosis	6.98e-05	0.000567	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PSMA2—osteoporosis	6.98e-05	0.000567	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PKM—osteoporosis	6.94e-05	0.000564	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—FDPS—osteoporosis	6.94e-05	0.000564	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	6.59e-05	0.000535	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PGLS—osteoporosis	6.58e-05	0.000535	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPD2—osteoporosis	6.58e-05	0.000535	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.52e-05	0.00053	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	6.5e-05	0.000528	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PKM—osteoporosis	6.36e-05	0.000517	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—FDPS—osteoporosis	6.36e-05	0.000517	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—OXCT1—osteoporosis	6.3e-05	0.000512	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CA2—osteoporosis	6.3e-05	0.000512	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CA2—osteoporosis	6.3e-05	0.000512	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—OXCT1—osteoporosis	6.3e-05	0.000512	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MGLL—osteoporosis	6.14e-05	0.000499	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—IDH2—osteoporosis	6.14e-05	0.000499	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MGLL—osteoporosis	6.14e-05	0.000499	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—POMC—osteoporosis	6.04e-05	0.000491	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPD2—osteoporosis	6.03e-05	0.00049	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PGLS—osteoporosis	6.03e-05	0.00049	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ATIC—osteoporosis	6.02e-05	0.000489	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PNP—osteoporosis	6.02e-05	0.000489	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—TGFB1—osteoporosis	5.96e-05	0.000484	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—TGFB1—osteoporosis	5.96e-05	0.000484	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PKM—osteoporosis	5.89e-05	0.000479	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—FDPS—osteoporosis	5.89e-05	0.000479	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—POMC—osteoporosis	5.81e-05	0.000472	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.79e-05	0.00047	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP27A1—osteoporosis	5.77e-05	0.000469	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	5.69e-05	0.000462	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP19A1—osteoporosis	5.66e-05	0.00046	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ACP5—osteoporosis	5.62e-05	0.000456	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PGLS—osteoporosis	5.59e-05	0.000454	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPD2—osteoporosis	5.59e-05	0.000454	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ATIC—osteoporosis	5.52e-05	0.000448	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PNP—osteoporosis	5.52e-05	0.000448	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	5.33e-05	0.000433	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—IDH2—osteoporosis	5.22e-05	0.000424	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TPI1—osteoporosis	5.22e-05	0.000424	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—IDH2—osteoporosis	5.22e-05	0.000424	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—OXCT1—osteoporosis	5.12e-05	0.000416	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CA2—osteoporosis	5.12e-05	0.000416	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PNP—osteoporosis	5.11e-05	0.000415	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ATIC—osteoporosis	5.11e-05	0.000415	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MGLL—osteoporosis	4.99e-05	0.000405	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—P4HB—osteoporosis	4.91e-05	0.000399	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP27A1—osteoporosis	4.91e-05	0.000399	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP27A1—osteoporosis	4.91e-05	0.000399	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—TGFB1—osteoporosis	4.84e-05	0.000393	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.83e-05	0.000393	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GAPDH—osteoporosis	4.82e-05	0.000391	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ACP5—osteoporosis	4.77e-05	0.000388	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ACP5—osteoporosis	4.77e-05	0.000388	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—TGFB1—osteoporosis	4.72e-05	0.000384	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.71e-05	0.000383	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—RAP1A—osteoporosis	4.69e-05	0.000381	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CA2—osteoporosis	4.69e-05	0.000381	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—OXCT1—osteoporosis	4.69e-05	0.000381	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.67e-05	0.000379	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ADCY5—osteoporosis	4.63e-05	0.000376	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GPX1—osteoporosis	4.61e-05	0.000374	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MGLL—osteoporosis	4.57e-05	0.000371	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.5e-05	0.000365	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.47e-05	0.000363	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TPI1—osteoporosis	4.44e-05	0.000361	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TPI1—osteoporosis	4.44e-05	0.000361	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CA2—osteoporosis	4.34e-05	0.000353	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—OXCT1—osteoporosis	4.34e-05	0.000353	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.31e-05	0.00035	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MTHFR—osteoporosis	4.25e-05	0.000346	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—IDH2—osteoporosis	4.24e-05	0.000345	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MGLL—osteoporosis	4.23e-05	0.000344	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—P4HB—osteoporosis	4.17e-05	0.000339	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—P4HB—osteoporosis	4.17e-05	0.000339	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GAPDH—osteoporosis	4.1e-05	0.000333	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GAPDH—osteoporosis	4.1e-05	0.000333	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—RAP1A—osteoporosis	3.99e-05	0.000324	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—RAP1A—osteoporosis	3.99e-05	0.000324	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP27A1—osteoporosis	3.99e-05	0.000324	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.92e-05	0.000318	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—IDH2—osteoporosis	3.89e-05	0.000316	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ACP5—osteoporosis	3.88e-05	0.000315	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ENO1—osteoporosis	3.79e-05	0.000308	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PSMA2—osteoporosis	3.74e-05	0.000304	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PSMA5—osteoporosis	3.74e-05	0.000304	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP27A1—osteoporosis	3.65e-05	0.000297	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.63e-05	0.000295	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TPI1—osteoporosis	3.61e-05	0.000293	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—IDH2—osteoporosis	3.6e-05	0.000292	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.57e-05	0.00029	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ACP5—osteoporosis	3.56e-05	0.000289	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.51e-05	0.000285	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.48e-05	0.000283	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.46e-05	0.000281	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.45e-05	0.00028	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.42e-05	0.000277	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—POMC—osteoporosis	3.4e-05	0.000276	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—P4HB—osteoporosis	3.39e-05	0.000275	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—osteoporosis	3.39e-05	0.000275	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP27A1—osteoporosis	3.38e-05	0.000275	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.35e-05	0.000272	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GAPDH—osteoporosis	3.33e-05	0.00027	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TPI1—osteoporosis	3.31e-05	0.000268	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ACP5—osteoporosis	3.29e-05	0.000267	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—RAP1A—osteoporosis	3.24e-05	0.000263	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ENO1—osteoporosis	3.23e-05	0.000262	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ENO1—osteoporosis	3.23e-05	0.000262	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PKM—osteoporosis	3.19e-05	0.000259	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FDPS—osteoporosis	3.19e-05	0.000259	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PSMA5—osteoporosis	3.18e-05	0.000258	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PSMA2—osteoporosis	3.18e-05	0.000258	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PSMA5—osteoporosis	3.18e-05	0.000258	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PSMA2—osteoporosis	3.18e-05	0.000258	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—P4HB—osteoporosis	3.11e-05	0.000252	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.1e-05	0.000252	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TPI1—osteoporosis	3.06e-05	0.000249	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GAPDH—osteoporosis	3.05e-05	0.000248	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP19A1—osteoporosis	3.03e-05	0.000246	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPD2—osteoporosis	3.02e-05	0.000245	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PGLS—osteoporosis	3.02e-05	0.000245	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.99e-05	0.000243	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—RAP1A—osteoporosis	2.97e-05	0.000241	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—P4HB—osteoporosis	2.88e-05	0.000234	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GAPDH—osteoporosis	2.82e-05	0.000229	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ATIC—osteoporosis	2.76e-05	0.000224	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PNP—osteoporosis	2.76e-05	0.000224	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—RAP1A—osteoporosis	2.75e-05	0.000223	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ENO1—osteoporosis	2.62e-05	0.000213	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.59e-05	0.00021	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PSMA2—osteoporosis	2.58e-05	0.00021	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PSMA5—osteoporosis	2.58e-05	0.00021	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP19A1—osteoporosis	2.58e-05	0.000209	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP19A1—osteoporosis	2.58e-05	0.000209	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ADCY5—osteoporosis	2.48e-05	0.000201	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GPX1—osteoporosis	2.47e-05	0.000201	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ENO1—osteoporosis	2.4e-05	0.000195	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PSMA2—osteoporosis	2.37e-05	0.000192	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PSMA5—osteoporosis	2.37e-05	0.000192	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CA2—osteoporosis	2.35e-05	0.000191	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—OXCT1—osteoporosis	2.35e-05	0.000191	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MGLL—osteoporosis	2.29e-05	0.000186	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MTHFR—osteoporosis	2.28e-05	0.000185	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ENO1—osteoporosis	2.22e-05	0.000181	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PSMA2—osteoporosis	2.19e-05	0.000178	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PSMA5—osteoporosis	2.19e-05	0.000178	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ADCY5—osteoporosis	2.11e-05	0.000171	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ADCY5—osteoporosis	2.11e-05	0.000171	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GPX1—osteoporosis	2.1e-05	0.000171	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GPX1—osteoporosis	2.1e-05	0.000171	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP19A1—osteoporosis	2.1e-05	0.00017	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—POMC—osteoporosis	2.08e-05	0.000169	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FDPS—osteoporosis	1.96e-05	0.000159	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PKM—osteoporosis	1.96e-05	0.000159	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—IDH2—osteoporosis	1.95e-05	0.000158	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MTHFR—osteoporosis	1.94e-05	0.000157	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MTHFR—osteoporosis	1.94e-05	0.000157	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP19A1—osteoporosis	1.92e-05	0.000156	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PGLS—osteoporosis	1.86e-05	0.000151	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPD2—osteoporosis	1.86e-05	0.000151	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP27A1—osteoporosis	1.83e-05	0.000149	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—POMC—osteoporosis	1.82e-05	0.000148	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.8e-05	0.000146	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.79e-05	0.000145	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ACP5—osteoporosis	1.78e-05	0.000145	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP19A1—osteoporosis	1.78e-05	0.000144	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ADCY5—osteoporosis	1.71e-05	0.000139	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX1—osteoporosis	1.71e-05	0.000139	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ATIC—osteoporosis	1.7e-05	0.000138	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PNP—osteoporosis	1.7e-05	0.000138	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.68e-05	0.000136	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.67e-05	0.000136	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TPI1—osteoporosis	1.65e-05	0.000134	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—osteoporosis	1.57e-05	0.000128	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ADCY5—osteoporosis	1.57e-05	0.000127	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX1—osteoporosis	1.56e-05	0.000127	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—P4HB—osteoporosis	1.56e-05	0.000126	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—POMC—osteoporosis	1.55e-05	0.000126	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—POMC—osteoporosis	1.55e-05	0.000126	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GAPDH—osteoporosis	1.53e-05	0.000124	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—RAP1A—osteoporosis	1.49e-05	0.000121	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ADCY5—osteoporosis	1.45e-05	0.000118	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX1—osteoporosis	1.45e-05	0.000118	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—OXCT1—osteoporosis	1.45e-05	0.000118	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CA2—osteoporosis	1.45e-05	0.000118	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—osteoporosis	1.44e-05	0.000117	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MGLL—osteoporosis	1.41e-05	0.000115	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—osteoporosis	1.34e-05	0.000109	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—POMC—osteoporosis	1.26e-05	0.000102	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ENO1—osteoporosis	1.2e-05	9.77e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—IDH2—osteoporosis	1.2e-05	9.74e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PSMA2—osteoporosis	1.18e-05	9.62e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PSMA5—osteoporosis	1.18e-05	9.62e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—POMC—osteoporosis	1.15e-05	9.37e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.13e-05	9.16e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ACP5—osteoporosis	1.1e-05	8.91e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—POMC—osteoporosis	1.07e-05	8.68e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TPI1—osteoporosis	1.02e-05	8.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP19A1—osteoporosis	9.61e-06	7.81e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—P4HB—osteoporosis	9.59e-06	7.79e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GAPDH—osteoporosis	9.41e-06	7.64e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RAP1A—osteoporosis	9.16e-06	7.44e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADCY5—osteoporosis	7.85e-06	6.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX1—osteoporosis	7.83e-06	6.36e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ENO1—osteoporosis	7.41e-06	6.02e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PSMA2—osteoporosis	7.3e-06	5.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PSMA5—osteoporosis	7.3e-06	5.93e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—osteoporosis	7.22e-06	5.87e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.92e-06	4.81e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—POMC—osteoporosis	5.78e-06	4.69e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADCY5—osteoporosis	4.84e-06	3.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX1—osteoporosis	4.82e-06	3.92e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—osteoporosis	4.45e-06	3.61e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—POMC—osteoporosis	3.56e-06	2.89e-05	CbGpPWpGaD
